Annual EBITDA
-$74.31 M
-$27.43 M-58.51%
December 31, 2022
Summary
- As of February 10, 2025, TALS annual EBITDA is -$74.31 million, with the most recent change of -$27.43 million (-58.51%) on December 31, 2022.
- During the last 3 years, TALS annual EBITDA has fallen by -$56.32 million (-312.88%).
Performance
TALS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$9.85 M
+$9.11 M+48.03%
June 30, 2023
Summary
- As of February 10, 2025, TALS quarterly EBITDA is -$9.85 million, with the most recent change of +$9.11 million (+48.03%) on June 30, 2023.
- Over the past year, TALS quarterly EBITDA has increased by +$8.01 million (+44.84%).
Performance
TALS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$67.34 M
+$8.01 M+10.63%
June 30, 2023
Summary
- As of February 10, 2025, TALS TTM EBITDA is -$67.34 million, with the most recent change of +$8.01 million (+10.63%) on June 30, 2023.
- Over the past year, TALS TTM EBITDA has dropped by -$4.46 million (-7.09%).
Performance
TALS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TALS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.5% | +44.8% | -7.1% |
| 3 y3 years | -312.9% | -112.5% | -607.5% |
| 5 y5 years | -312.9% | -101.8% | -1279.3% |
TALS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +58.5% | at low | at high | +95.6% | +43.6% | +11.9% |
| 5 y | 5-year | +312.9% | at low | +112.5% | +95.6% | +1279.3% | +11.9% |
| alltime | all time | +312.9% | at low | +112.5% | +95.6% | +1279.3% | +11.9% |
Talaris Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$9.85 M(-48.0%) | -$67.34 M(-10.6%) |
| Mar 2023 | - | -$18.96 M(-1.6%) | -$75.35 M(+1.4%) |
| Dec 2022 | -$74.31 M(+58.5%) | -$19.27 M(+0.1%) | -$74.31 M(+7.3%) |
| Sep 2022 | - | -$19.25 M(+7.8%) | -$69.24 M(+10.1%) |
| Jun 2022 | - | -$17.86 M(-0.3%) | -$62.88 M(+12.4%) |
| Mar 2022 | - | -$17.93 M(+26.2%) | -$55.94 M(+19.3%) |
| Dec 2021 | -$46.88 M | -$14.20 M(+10.2%) | -$46.88 M(+19.0%) |
| Sep 2021 | - | -$12.89 M(+18.0%) | -$39.39 M(+21.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$10.92 M(+23.2%) | -$32.51 M(+24.0%) |
| Mar 2021 | - | -$8.87 M(+32.2%) | -$26.23 M(+17.9%) |
| Dec 2020 | -$22.24 M(+23.5%) | - | - |
| Dec 2020 | - | -$6.71 M(+11.7%) | -$22.24 M(+43.2%) |
| Sep 2020 | - | -$6.01 M(+29.6%) | -$15.53 M(+63.1%) |
| Jun 2020 | - | -$4.64 M(-5.0%) | -$9.52 M(+95.0%) |
| Mar 2020 | - | -$4.88 M | -$4.88 M |
| Dec 2019 | -$18.00 M | - | - |
FAQ
- What is Talaris Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Talaris Therapeutics?
- What is Talaris Therapeutics annual EBITDA year-on-year change?
- What is Talaris Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Talaris Therapeutics?
- What is Talaris Therapeutics quarterly EBITDA year-on-year change?
- What is Talaris Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Talaris Therapeutics?
- What is Talaris Therapeutics TTM EBITDA year-on-year change?
What is Talaris Therapeutics annual EBITDA?
The current annual EBITDA of TALS is -$74.31 M
What is the all time high annual EBITDA for Talaris Therapeutics?
Talaris Therapeutics all-time high annual EBITDA is -$18.00 M
What is Talaris Therapeutics annual EBITDA year-on-year change?
Over the past year, TALS annual EBITDA has changed by -$27.43 M (-58.51%)
What is Talaris Therapeutics quarterly EBITDA?
The current quarterly EBITDA of TALS is -$9.85 M
What is the all time high quarterly EBITDA for Talaris Therapeutics?
Talaris Therapeutics all-time high quarterly EBITDA is -$4.64 M
What is Talaris Therapeutics quarterly EBITDA year-on-year change?
Over the past year, TALS quarterly EBITDA has changed by +$8.01 M (+44.84%)
What is Talaris Therapeutics TTM EBITDA?
The current TTM EBITDA of TALS is -$67.34 M
What is the all time high TTM EBITDA for Talaris Therapeutics?
Talaris Therapeutics all-time high TTM EBITDA is -$4.88 M
What is Talaris Therapeutics TTM EBITDA year-on-year change?
Over the past year, TALS TTM EBITDA has changed by -$4.46 M (-7.09%)